Results from the PCPT trial[29], which offered prostate biopsy to all subjects (independent of their PSA level), demonstrated that as many as 15% of men with a PSA value less than 3.0 ng/mL had prostate cancer and that 15% of these cancers were high grade. The gene discussed is KLK3; the disease is Familial prostate cancer.